ACTUATE THERAPEUTICS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Operating income | -$22.5 | -$25.2 | -$25.0 | — |
| Net income | -$22.2 | -$27.3 | -$24.7 | — |
Shares outstanding 24.0M · Free float 37.9%
Annual filing data through FY ended December 31, 2025; float as of October 3, 2026.
XBiotech Leads Buying Intensity; Gold.com Draws $3.93 Million